FDA approves Teva's generic of Mylan's EpiPen
The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Allergy | Allergy & Immunology | Food and Drug Administration (FDA) | Health | Healthcare Costs